WO2014026271A1 - Gradients chimiques de surface - Google Patents

Gradients chimiques de surface Download PDF

Info

Publication number
WO2014026271A1
WO2014026271A1 PCT/CA2013/000716 CA2013000716W WO2014026271A1 WO 2014026271 A1 WO2014026271 A1 WO 2014026271A1 CA 2013000716 W CA2013000716 W CA 2013000716W WO 2014026271 A1 WO2014026271 A1 WO 2014026271A1
Authority
WO
WIPO (PCT)
Prior art keywords
orifice
substrate
chemical
gradient
chemical compound
Prior art date
Application number
PCT/CA2013/000716
Other languages
English (en)
Inventor
Gerardo A. Diaz-Quijada
Danial D.M. Wayner
Christophe Py
Geoff MEALING
Original Assignee
National Research Council Of Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Research Council Of Canada filed Critical National Research Council Of Canada
Publication of WO2014026271A1 publication Critical patent/WO2014026271A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/18Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/32Materials or treatment for tissue regeneration for nerve reconstruction
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D2490/00Intermixed layers
    • B05D2490/60Intermixed layers compositions varying with a gradient parallel to the surface

Definitions

  • the present invention relates to methods of modifying surfaces of substrates and modified surfaces prepared by such methods.
  • the method relates to methods of producing chemical gradients on surfaces and to surfaces having chemical gradients prepared thereon.
  • Chemical gradients are not only interesting systems for fundamental studies, but also play a key role in defining and regulating biological phenomena.
  • Surface-immobilized chemical gradients are important systems employed in the study of molecular recognition of the cellular microenvironment that triggers growth, differentiation, and communication.
  • Of particular interest is the study of cell patterning or guidance, which has applications that span from fundamental studies to numerous biochip technologies.
  • a syringe pump may be used to place a droplet of a chemical solution at a spot on a surface permitting the droplet to radially expand away from the spot by diffusion, further assisted by the pressure of adding more droplets to the spot (Spencer 2004; Spencer 2009).
  • a chemical may be print stamped on to a surface as a round spot or ring away from which the chemical diffuses to create a radial gradient (Morgenthaler 2008).
  • a fill system using a nozzle with multiple apertures may be used to spray a chemical solution on to a surface in a desired pattern to form a chemical gradient on the surface (Jenkins 2005). In general, a variety of strategies for forming chemical gradients on surfaces are known (Ruardy 1997; Singh 2008).
  • Patch clamp technologies are also known in the art (e.g. Huang 2005; Huang 2002; Kelly 2002; Vogel 2003).
  • a cell is moved, positioned and sealed over a hole in a substrate by using mechanical, electroosmotic or electrophoretic techniques.
  • a coating with a specific binding member e.g. ligand, receptor, antibody, etc.
  • ligand, receptor, antibody, etc. can be localized around the holes to induce adhesion and create a better seal between the cell membrane and substrate surface.
  • such technology does not use a gradient, which is desirable to enhance a self-guided placement/attachment over the hole.
  • a method of producing a radial chemical gradient on a surface of a substrate comprising: controllably forcing a predetermined amount of a chemical compound through an orifice in the substrate, the orifice connecting a first surface on which the gradient is produced to a second surface of the substrate, the chemical compound being forced through the orifice in a direction from the second surface to the first surface; and, allowing the chemical compound to diffuse radially away from the orifice through which the compound is being forced, the compound reacting with the first surface to form a radial chemical gradient on the first surface disposed around the orifice, the gradient having lower concentrations of the chemical compound at distances farther from the orifice.
  • a substrate comprising a radial chemical gradient thereon produced by a method of the present invention.
  • Means for controllably forcing the chemical compound through the orifice include, for example, mechanical pumping, capillary action with or without the aid of electro- wetting, electrically driven methods or combinations thereof. Capillary action or electrically driven methods are preferred. Electrically driven methods including, for example, electrophoretic and electroosmotic techniques, require an ionically conductive medium on both sides of the surface. Electrically driven methods are highly desirable since these methods can not only drive precise quantities of the desired compound through the orifice but are also suitable for orifices with micron and sub-micron diameters where mechanical pumping would require prohibitively high pressures. Moreover, electrical pulses with sufficiently high potential differences have the added advantage of removing small air bubbles trapped at or within the orifice.
  • Electroosmotic behavior is observed when the surface of the channel is charged either intrinsically or due to surface modification. Moreover, this behavior is predominantly obtained when the charged surface is free of adventitious organic compounds and when the diameter of the channel is sufficiently small. Electrophoretic behavior is observed when the surface of the channel is not charged (as it is the case in plastics) or not sufficiently charged (as may be the case for silicon-nitride). Electrically driven methods may use applied voltages in a range of about 10-200 V (e.g. about 100 V) at pulse rates of about 10-5000 msec (e.g. about 100-3000 msec) with polarity reversal to force the chemical compound back through the orifice after the chemical reaction at the surface. Other schemes may be advantageous depending on the configuration and end-goal.
  • Geometry and surface chemistry (e.g. hydrophilic and hydrophobic properties) within the orifice has a large effect on the flow of the chemical compound through the orifice when capillary action or electrically driven methods are used.
  • the orifice preferably has a diameter in the micron or sub-micron range, for example, in a range of from about 1 nm to about 1000 ⁇ , more preferably in a range of from about 10 nm to about 500 ⁇ ⁇ .
  • the diameter is preferably between about 1 and 2 ⁇ , though it may be smaller or larger depending on the type of cell interrogated.
  • the chemical compound to be imprinted as a chemical gradient may be in the form of a solution or neat liquid, aerosol or gas.
  • Characteristics of the chemical gradient can be controlled by the viscosity of the solution, the amount of solution being passed through, pH and temperature of the solution.
  • Solution viscosity controls the diffusion rate of the solution that has passed through the hole and this can be adjusted by choosing a solvent with the appropriate viscosity and/or dissolving an inert polymer (e.g. poly(ethylene glycol) (PEG)).
  • PEG poly(ethylene glycol)
  • the amount of solution that is forced through the orifice can be adjusted by varying the potential difference that is applied and by the length of the electrical pulse at a given ionic strength and viscosity.
  • the chemical gradient may be radially symmetric or asymmetric disposed around the orifice. Higher concentrations of the compound in the gradient will be found closer to the orifice since the areas of the substrate surface in proximity to the orifice are in contact with the compound for a longer period of time.
  • Asymmetric gradients may be formed by controlling the direction of diffusion of the chemical compound on the first surface.
  • asymmetric gradients may be formed by inhibiting and/or encouraging diffusion of the chemical compound in certain directions away from the orifice. Inhibition of diffusion may be accomplished by any suitable means, for example by placing physical or chemical features in the diffusion path to guide diffusion in certain directions.
  • placing an electrode laterally away from the orifice but close to the surface on which the gradient is being produced would encourage diffusion in the direction of the electrode.
  • biasing of the gradient in a particular direction may be performed under the influence of an electric field.
  • Asymmetric gradients may be particularly desirable not only for cell placement but also axon guidance.
  • the chemical gradient is centered on the orifice.
  • Any suitable chemical compounds may be used to form gradients on the surface of the substrate.
  • the type of compound is limited by its ability to diffuse along and react with the surface. Further, the compound used will depend on its ultimate application as the compound should possess reactive or bioactive moieties that can be used to immobilize objects of interest (e.g. cells via cell adhesion) on the substrate over the orifices.
  • Suitable chemical compounds include, for example, cell adhesion promoters such as poly-D-lysine, poly(ethyleneimine), collagen, fibronectin, laminin and of particular interest, peptides that contain the RGD motif.
  • peptides are able to bind to the integrin receptor on the surface of the cells thereby inducing cell adhesion via a molecular recognition event. Furthermore, the integrin receptors are in close proximity to ion channels and therefore provide the means to position the ion channels on or next to the orifice. This is extremely important for electrophysiology since ion channels govern the electrical activity of neurons and their abnormal behavior give rise to neurological diseases.
  • the chemical compound is immobilized on the surface of the substrate.
  • the chemical compound may react directly with the substrate surface to be bound thereon.
  • the surface may be chemically or physically prepared in order to react with the chemical compound.
  • An example of chemical preparation includes modifying the surface with functional groups, for example, N-hydroxysuccinimide (NHS) ester groups, maleimide groups, epoxy groups, azide groups (for "click chemistry"), etc.
  • Substrates may comprise any suitable material, for example, silicon, glass, quartz or plastic (e.g. polystyrene, polycarbonate, polyimides, etc.).
  • the substrate may be in the form of cell culture plates, biochips (e.g. planar patch-clamp arrays, multi-electrode arrays), chemical sensors, etc.
  • the present invention is particularly suited to patch-clamp array technologies.
  • the patch-clamp technique employing a fine-aperture (usually 1-2 pm) glass micropipette filled with an electrochemically conductive physiological medium, is used to contact individual cells cultured in vitro and record the electrophysiological activity of either individual ion channel proteins, or the entire cell.
  • Ion channels are specialized transmembrane proteins that selectively control the flow of specific ions through the membrane, thereby allowing cells to control their membrane potential. This process enables cells to be "excitable”, to generate action potentials to process and transmit information in many biological systems including, but not limited to the nervous system. Neuropathologies are associated with altered elecrophysiological activity such as synaptic dysfunction and altered ion channel activity; in vitro disease models are often used to assess therapeutic strategies by studying those particular ion channels. Because of its superior sensitivity and spatial resolution compared to other techniques, the patch- clamp technique is considered the gold standard of ion-channel electrophysiology and is essential to ion-channel pharmacology. It is however a slow and cumbersome technique that requires high technical skill.
  • APS Automated Patch-clamp Systems
  • the aperture at the apex of the pipette is replaced by an approximately micron size orifice in a membrane that separates the culture vial from a second bath containing the same electrochemically conductive physiological medium as found inside the pipette.
  • APSs critically increase throughput for primary drug screening, but they can only interrogate isolated cells from suspensions. Moreover, these cells are from cell lines that have homogenous over-expressed ion channels. For this reason, and since every function in the brain and nervous system is effected by networks of cells, these are not particularly biologically relevant models of disease.
  • patch-clamp array chip technology has been proposed where several orifices are integrated in the patch- clamp chip, each connected to a dedicated subterranean microfluidic channel to enable the simultaneous monitoring of several neurons cultured on-chip and engaged in network activity (Mealing 2005; Mealing 201 1 ).
  • Multi-Electrode arrays a commercially available type of neurochip that allows the electrophysiological monitoring of large networks of electrogenic cells (Fejtl 2006), albeit not at the resolution of individual cells or ion channel proteins.
  • Multi-electrode arrays could be equipped with perfusion holes for the creation of chemical gradients for positioning cells over or near the electrodes in a predefined pattern.
  • the present method and surfaces are particularly useful for producing surface- immobilized chemical gradients especially for the study of molecular recognition of biological events.
  • Of particular interest is the study of cell patterning and/or axon guidance, which has a large number of applications that span from fundamental studies to biochip technologies.
  • Synthetic cellular networks can be used as in vitro brain models, to simulate neurological dysfunction, and to evaluate therapeutic strategies to restore those functions. These studies may help health researchers better understand the mechanisms of action of neurological diseases, and pharmacologists to discover new drugs. Brain models may also be subjected to various substances affecting their normal spontaneous activity, and the altered function of the model allows one to infer the properties of that substance. For example, sampling the bodily fluid of a patient (i.e. cerebrospinal fluid) on the model and observing an altered behavior of the network that is the signature of a disease may lead to diagnosis. Sampling a treatment on the model may also be an effective means of assessing its efficacy for the patient. Also, sampling food or water extracts on the model may be an effective and sensitive means of detecting neurotoxins or assessing food safety.
  • bodily fluid of a patient i.e. cerebrospinal fluid
  • Sampling a treatment on the model may also be an effective means of assessing its efficacy for the patient.
  • Synthetic cellular networks can additionally be implanted in vivo as either grafts to replace damaged tissue, or as functional interfaces with prostheses. For example, it is well known that severed nerves often cannot reconnect without intervention, and grafts of tissue cultured in vitro and organized in a morphologically compatible manner may result in restored function. The present method could therefore be used to synthesize a cellular network in vitro resulting in a tissue that can be lifted from the substrate and implanted in vivo for restorative purposes.
  • Neural implants are routinely implanted in certain patients to alleviate the symptoms of disease (i.e. epilepsy or depression) or restore lost function (i.e. bladder control), but the electrical-nerve interfaces are of poor quality and durability due to the accumulation of scar tissue around the implant. Again, synthetic tissue cultured in vitro on the implant before implantation may lead to the development of a better interface.
  • cell positioning may be used for the purpose of cell sorting (Yamamura 2005).
  • the combination of cell positioning and the specific interaction with an antigen may result in the identification of specific cells within a larger population. It is an important advantage that the present method is self-aligning, that is, the gradient may be centered on the orifice since it uses the orifice for diffusion of the chemical compound.
  • most printing methods may be able to achieve high resolution and similar gradient shapes, but they face the difficulty of alignment.
  • the dispensing of fluids from any kind of printer is generally limited to a resolution of about 20 pm therefore printing cannot achieve the precision needed for aligning synthetic cellular networks on patch-clamp array chip orifices, given that the cells of interest can be roughly 10 pm and the orifice 1 pm in diameter.
  • nm resolution e.g. dip-pen nanolithography
  • these devices have nanometer resolution, they cannot easily print large areas. For instance, it would be very impractical, if not impossible, to print a 10 pm spot using commercial printing products that can print with nm resolution.
  • the present invention can easily produce radial chemical gradients aligned on an orifice and having a resolution of gradient concentrations in a range of about 500 nm to 10 pm. Further features of the invention will be described or will become apparent in the course of the following detailed description.
  • Fig. 1A depicts a schematic diagram illustrating a method of the present invention for immobilizing a radial gradient of poly-D-lysine on a silicon chip
  • Fig. 1 B depicts a fluorescent image of the gradient of fluorescently labeled poly-D- lysine formed on the silicon chip as illustrated in Fig. 1A centered on an orifice;
  • Fig. 2 depicts images of primary rat cortical neurons cultured on orifices of a silicon chip on which a radial gradient of poly-D-lysine has been formed as depicted in Fig. 1A and Fig. 1 B. Description of Preferred Embodiments
  • Example 1 Formation of radial gradient of poly-D-lysine on a silicon chip
  • Fig. A an electroosmotic device is depicted in which solution 1 of poly-D-lysine is provided below silicon chip 5 having micro-sized orifice 3.
  • the chip separates the poly-D-lysine solution 1 from poly-D-lysine-free solvent 9 above the chip in order to provide a concentration difference of poly-D-lysine across the orifice.
  • Solution 1 and solvent 9 are kept separated to prevent mixing except through the orifice.
  • Power supply 7 provides a potential difference across electrodes 11 and 13. Molecules of poly- D-lysine are forced through the orifice driven to the positively charged electrode 11 above the chip provided the channel is negatively charged (see inset).
  • Poly-D-lysine then diffuses radially away from the orifice and reacts with upper surface 15 of chip 5, which has been modified chemically with highly reactive N-hydroxysuccinimide (NHS) ester groups that have been immobilized on the chip's surface.
  • NHS N-hydroxysuccinimide
  • These highly reactive NHS ester groups react with amino groups of the poly-D-lysine forming stable amide linkages, thereby immobilizing the poly-D-lysine on the chip. It will be apparent to those skilled in the art that the position of electrode 11 has an influence on the way poly-D-lysine diffuses from the orifice. If electrode 11 is positioned directly above the orifice, the resulting gradient is expected to be substantially symmetrical.
  • Electrodes 11 Should electrode 11 be positioned substantially on one side of the orifice, the gradient will be biased towards it. Additional electrodes, or electrodes of various shapes and sizes, may be advantageously positioned in the bath in order to produce chemical gradients of various shapes. Generally, it will also be apparent to those skilled in the art that other methods, such as aspiration, may influence the diffusion of chemical compounds away from the orifice, and therefore affect the shape of the chemical gradient being immobilized on the surface of the substrate.
  • Silicon chips were coated with a thin film of silicon dioxide using a Plasma Enhanced Vapor Chemical Deposition at 350°C and 40 W power with gas flow rates set at 500 seem N 2 0, 54 seem SiH 4 and 100 seem He and a pressure of 1500 mTorr. The deposition rate was approximately 350 A/min to yield 200 nm films. Subsequently, the chips were cleaned in a standard piranha solution at 120°C for at least 2 hours. The dry substrates placed inside a chamber containing two microcentrifuge tubes with 15 ⁇ _ of 3-aminopropyltriethoxysilane (APTES) and allowed to react for 4 hours under vacuum.
  • APTES 3-aminopropyltriethoxysilane
  • 0.1 M borate buffer pH 8 in the presence of 9.6 mM N-(3-dimethylaminopropyl)-N'- ethylcarbodiimide hydrochloride (EDC, Aldrich, Oakville, ON, Canada) and 8.6 m
  • SDS sodium dodecylsulfate
  • the carboxylic acid terminated substrates were activated (formation of surface NHS esters) in a solution containing 9.6 mM EDC and 8.6 mM NHS in nitromethane for 2 hours.
  • the freshly activated substrates were stored in a desiccator and employed immediately in the preparation of gradients.
  • top electrode is carefully positioned above the hole while ensuring it is immersed in the solution.
  • the bottom platinum electrode 13 is in contact with the solution in the fluidic channel.
  • Top platinum electrode 11 is positioned with the aid of a 3-axes micrometer driven translation stage.
  • a potential difference of 100 V is applied for 100 msec and the plug of polylysine is allowed to diffuse and react with NHS-activated surface 15 for 1000 msec before applying a potential difference with reverse polarity for 3000 msec.
  • gradients can be prepared without mounting the silicon chip to substrate with fluidics. That is, the chip is held with an appropriate holder that allows the placement of small volumes (3 pL) of solutions (same as above) at the orifice of the chip. In this case, the volume of the solution is small enough that it stays in place.
  • the holder can be designed in such a manner that the bottom platinum electrode is aligned and close enough to the orifice to allow contact with the 3 pL solution.
  • the top platinum electrode can be position with a translation stage in the same manner as before ensuring that it is in contact with the 3 pL solution.
  • Fig. 1 B depicts the radial chemical gradient of poly-D-lysine formed on the silicon chip centered on the orifice. It is evident from the intensity that there is greater concentration of poly-D-lysine near the center where the orifice is located, and that the concentration falls off gradually farther from the orifice.
  • the diameter of the gradient is about 25 ⁇ at half-height.
  • Example 2 Immobilization and culturing of cells on patch-clamp array chips prepared with a radial gradient of poly-D-lysine around an orifice
  • rat cortical neurons were cultured on the orifices of silicon chips prepared with a radial gradient of poly-D-lysine as described in Example 1. The chips were stained with calcein (cell viability) and with RH-237 (a membrane stain) to detect where the cells were growing. Thus, embryonic day E18 rat cortical neurons were harvested as a suspension with a stock density of 1.3x10 6 cells/ml in a growing medium that comprised EMEM supplemented with 21 mM glucose, 10% fetal bovine serum, and 10% horse serum.
  • Chips were sterilized for 30 minutes using 70% ethanol and subsequently transferred into a 24-well plate.
  • Cells were plated by placing 500 ⁇ of the above stock cell suspension in each well. Cell cultivation was carried out in an incubator set at 37.3°C and 5.3% C0 2 . Half of the culture media was replaced after one week of plating (7 DIV). After 14 days in culture, cells were stained as described below.
  • Bath Medium (BM) was prepared as follows: 140 mM NaCI, 3.5 mM KCI, 0.4 mM KH 2 P0 4 , 20 mM HEPES, 5 mM NaHC0 3 , 1.2 mM MgS0 4 , 1.3 mM CaCI 2 , and 15 mM glucose.
  • Calcein-AM (MolecularQ2 Probes, C-3100), was used as an indicator to access cell viability.
  • a 5 mM stock solution was prepared in DMSO with vigorous vortexing. The stock solution was then diluted to a 40 ⁇ sub-stock in BM. Cells were subsequently stained using Calcien-AM at 5 ⁇ .
  • a 10 mM stock solution of RH-237 was prepared and subsequently diluted to 50 ⁇ in BM for cell staining. Each sample was placed in an individual well of a 24-well plate. 350 mL of 5 mM calcein were placed in each well before incubation for 30 min at 37°C in the dark.
  • FIG. 2 depicts optical images A) of the cells on the chips, and fluorescent images of the stained cells where B) are calcein-stained cells and C) are RH-237-stained cells.
  • the arrows indicate the location of orifices. It is evident from Fig. 2 that a cell is localized over the orifice, demonstrating the efficacy of the poly-D-lysine gradients prepared in the manner described in Example 1 for localizing cells cultured on the silicon chip. This should permit monitoring the activity of individual cells engaged in network activity at the high resolution when employing a multi-orifice patch-clamp chip.
  • Chemical gradients of appropriate biomolecules can also be employed in axon guidance since they mimic molecular signaling necessary for forming neural networks. Asymmetric gradients are particularly useful in this regard.
  • Huang M Wang X, Wu L, Yang W, Cheng J. (2002) Active and Biocompatible Platforms Prepared by Polymerization of Surface Coating Films. United States Patent Publication US 2002-0123134 published September 5, 2002. Huang M, Rothwarf D, Xu J, Wang X, Wu L, Guia A. (2005) Biochips Including Ion Transport Detecting Structures and Methods of Use. United States Patent Publication US 2005-0266478 published December 1 , 2005.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Botany (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

L'invention concerne un procédé de production d'un gradient chimique radial sur une surface d'un substrat comprenant le passage par la contrainte d'une quantité prédéterminée d'un composé chimique à travers un orifice dans le substrat de manière réglable. L'orifice raccorde une surface sur laquelle le gradient est produit à une autre surface du substrat et le composé chimique est contraint à passer à travers l'orifice dans une direction allant de l'autre surface vers la surface sur laquelle le gradient est produit. La diffusion du composé chimique est permise sur la surface radialement depuis l'orifice et le composé réagit avec la surface pour former le gradient chimique radial sur la surface disposée autour de l'orifice.
PCT/CA2013/000716 2012-08-17 2013-08-15 Gradients chimiques de surface WO2014026271A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261684178P 2012-08-17 2012-08-17
US61/684,178 2012-08-17

Publications (1)

Publication Number Publication Date
WO2014026271A1 true WO2014026271A1 (fr) 2014-02-20

Family

ID=50101148

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2013/000716 WO2014026271A1 (fr) 2012-08-17 2013-08-15 Gradients chimiques de surface

Country Status (1)

Country Link
WO (1) WO2014026271A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2568456C1 (ru) * 2014-11-20 2015-11-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Уральский федеральный университет имени первого Президента России Б.Н. Ельцина" Способ получения имплантированного ионами цинка кварцевого стекла

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020164777A1 (en) * 2001-02-09 2002-11-07 Kelly Andrew J.G. Devices and methods for high throughput patch clamp assays
US20030015495A1 (en) * 2001-05-16 2003-01-23 Jan Genzer Methods for forming tunable molecular gradients on substrates

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020164777A1 (en) * 2001-02-09 2002-11-07 Kelly Andrew J.G. Devices and methods for high throughput patch clamp assays
US20030015495A1 (en) * 2001-05-16 2003-01-23 Jan Genzer Methods for forming tunable molecular gradients on substrates

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2568456C1 (ru) * 2014-11-20 2015-11-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Уральский федеральный университет имени первого Президента России Б.Н. Ельцина" Способ получения имплантированного ионами цинка кварцевого стекла

Similar Documents

Publication Publication Date Title
US10753925B2 (en) Devices comprising muscle thin films and uses thereof in high throughput assays for determining contractile function
DE60003171T2 (de) Methoden zur miniaturisierten zellenanordnung und auf zellen basierendes screening gerät
US8709744B2 (en) Manufacturing process for cellular screening substratum, resultant substratum, and method and apparatus for screening
US7244349B2 (en) Multiaperture sample positioning and analysis system
US7201836B2 (en) Multiaperture sample positioning and analysis system
Hanson Shepherd et al. 3D microperiodic hydrogel scaffolds for robust neuronal cultures
US20090153153A1 (en) Multiaperture sample positioning and analysis system
JP2008509709A (ja) 空間的に限定されたエレクトロポレーション方法およびその装置
Turcu et al. Ink-jet printing for micropattern generation of laminin for neuronal adhesion
WO2018027105A1 (fr) Procédés de microstructuration optique d'hydrogels et leurs utilisations
Gooding et al. Molecularly engineered surfaces for cell biology: from static to dynamic surfaces
US20080248972A1 (en) Method of Immobilizing Protein, Protein Chip, Method of Immobilizing Cell and Cell Chip
US10352924B2 (en) Nanofibrous photoclickable hydrogel microarrays
JP5130376B2 (ja) 三次元細胞培養体の生体シグナルの検出方法及び検出キット
Py et al. From understanding cellular function to novel drug discovery: the role of planar patch-clamp array chip technology
Li et al. Construction of dopamine-releasing gold surfaces mimicking presynaptic membrane by on-chip electrochemistry
CA3043708A1 (fr) Plates-formes de puce pour la bio-impression 3d de microreseau
JP2007504818A (ja) 細胞内組織の接着制御のための方法及び装置
JP2007504818A5 (fr)
JP4378069B2 (ja) 細胞スクリーニング基板とその製造方法、それを用いた細胞スクリーニング法および細胞スクリーニング装置
WO2014026271A1 (fr) Gradients chimiques de surface
WO2007063736A1 (fr) Puce de microréseau, réseau cellulaire l’utilisant et méthode pour la produire
Jeon et al. Neuroligin-1-Modified Electrodes for Specific Coupling with a Presynaptic Neuronal Membrane
Cheng et al. “Chip-on-a-Transwell” Devices for User-Friendly Control of the Microenvironment of Cultured Cells
Stil et al. A simple method for poly-D-lysine coating to enhance adhesion and maturation of primary cortical neuron cultures in vitro

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13830022

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13830022

Country of ref document: EP

Kind code of ref document: A1